The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Hydroxymethyl-5-{6-[(pyridin-3-ylmethyl)-amino]-purin-9-yl}-tetrahydro-furan-3,4-diol ID: ALA609945
PubChem CID: 10109035
Max Phase: Preclinical
Molecular Formula: C16H18N6O4
Molecular Weight: 358.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: OC[C@H]1OC(n2cnc3c(NCc4cccnc4)ncnc32)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C16H18N6O4/c23-6-10-12(24)13(25)16(26-10)22-8-21-11-14(19-7-20-15(11)22)18-5-9-2-1-3-17-4-9/h1-4,7-8,10,12-13,16,23-25H,5-6H2,(H,18,19,20)/t10-,12-,13-,16?/m1/s1
Standard InChI Key: OGGGQWLDZCHKIQ-AARXTDBFSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
5.2292 -5.1667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2167 -6.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6542 -4.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6542 -4.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2292 -4.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0292 -7.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5875 -4.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 -6.2042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4292 -7.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2417 -6.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -4.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -5.2875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6167 -4.3792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -3.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6167 -4.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -1.6875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3917 -7.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6042 -2.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0542 -7.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6042 -3.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6750 -6.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -2.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -6.7667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5917 -1.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0792 -2.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0750 -1.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 1 0
5 7 2 0
6 2 1 0
7 1 1 0
8 2 1 0
9 6 1 0
10 8 1 0
11 4 2 0
12 3 2 0
13 15 2 0
14 11 1 0
15 12 1 0
16 22 1 0
6 17 1 6
18 20 1 0
9 19 1 6
20 14 1 0
10 21 1 1
22 18 2 0
23 21 1 0
24 26 1 0
25 18 1 0
26 25 2 0
4 5 1 0
9 10 1 0
13 11 1 0
24 16 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.36Molecular Weight (Monoisotopic): 358.1390AlogP: -0.56#Rotatable Bonds: 5Polar Surface Area: 138.44Molecular Species: NEUTRALHBA: 10HBD: 4#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.45CX Basic pKa: 5.06CX LogP: -1.28CX LogD: -1.28Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.47Np Likeness Score: 0.21
References 1. Kusachi S, Thompson RD, Yamada N, Daly DT, Olsson RA.. (1986) Dog coronary artery adenosine receptor: structure of the N6-aryl subregion., 29 (6): [PMID:3012086 ] [10.1021/jm00156a016 ]